Membrane-intercalated proteoglycan of a stroma-inducing clone from Lewis lung carcinoma binds to fibronectin via its heparan sulfate chains.
A Lewis lung carcinoma-derived low metastatic clone, P29, with a capacity to induce a fibrotic stromal response of host tissue, exhibits tumorigenesis depending on an interstitial matrix formed by the induced stromal cells. Using this clone, in the present study we isolated and characterized a membrane-intercalated proteoglycan that mediates interaction between the tumor cells and interstitial matrix. The tumor cells were cultured in the presence of [3H]glucosamine and [35S]sulfate or [35S]methionine, and hydrophobic proteoglycans were isolated by chromatography on DEAE-Sephacel and then Octyl-Sepharose CL-4B. Proteoglycans with high affinity to the octylresidue were obtained from the cell layer but not to any significant extent from the medium. By CsCl density gradient centrifugation, they were separated into bottom, middle, and top subfractions, which were shown to consist of homogeneous species with estimated M(r) values of 270,000 (named CPGIIIB), 200,000 (CPGIIIM), and 195,000 (CPGIIIT), respectively, by gel filtration on Sepharose CL-4B. These proteoglycans were intercalated into phosphatidylcholine liposomes, suggesting that they are all membrane-intercalated proteoglycans. Analyses of their glycosaminoglycans with chondroitinase ABC and heparitinase I plus II demonstrated that they all contain heparan sulfate as a major glycosaminoglycan (58-85%) and chondroitin 4-sulfate as a minor one (15-42%). Of these three proteoglycans, only CPGIIIB proteoglycan bound specifically to fibronectin-Sepharose 4B under physiological conditions. Molecular analyses of this proteoglycan by Sepharose CL-4B or SDS-PAGE before and after treatments with glycosaminoglycan degradation enzymes or trifluoromethanesulfonic acid demonstrated that CPGIIIB proteoglycan is a hybrid proteoglycan having heparan sulfate and chondroitin 4-sulfate chains on the same core protein with an M(r) of 40,000. Affinity chromatographies of the CPGIIIB proteoglycan on fibronectin-Sepharose 4B after treatments with these enzymes demonstrated that it bound to fibronectin via its heparan sulfate chains. On the basis of the above results, we propose that the CPGIIIB proteoglycan mediates the interaction between the tumor cells and interstitial matrix.
Itano
N
N
Clinical Research Institute, National Nagoya Hospital.
Oguri
K
K
Nakanishi
H
H
Okayama
M
M
D000818:Animals; D002236:Carbohydrate Conformation; D002277:Carcinoma / Q000737:chemistry*; D002999:Clone Cells; D003094:Collagen / Q000276:immunology; D005353:Fibronectins / Q000737:chemistry* / Q000276:immunology; D006493:Heparin / Q000737:chemistry*; D006497:Heparan Sulfate / Q000737:chemistry* / Q000302:isolation & purification; D007106:Immune Sera; D007150:Immunohistochemistry; D008175:Lung Neoplasms / Q000737:chemistry* / Q000473:pathology; D008562:Membrane Glycoproteins / Q000737:chemistry*; D051379:Mice; D011485:Protein Binding; D011509:Proteoglycans / Q000737:chemistry* / Q000302:isolation & purification; D017154:Stromal Cells / Q000737:chemistry / Q000187:drug effects; D014407:Tumor Cells, Cultured
D003094:Collagen; D005353:Fibronectins; D006493:Heparin; D006497:Heparan Sulfate; D007106:Immune Sera; D008562:Membrane Glycoproteins; D011509:Proteoglycans